The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

Somatostatin Analogue Treatment of a TSH-Secreting Adenoma Presenting With Accelerated Bone Metabolism and a Pericardial Effusion: A Case Report.

TitleSomatostatin Analogue Treatment of a TSH-Secreting Adenoma Presenting With Accelerated Bone Metabolism and a Pericardial Effusion: A Case Report.
Publication TypeJournal Article
Year of Publication2016
AuthorsMousiolis, A. C., Rapti E., Grammatiki M., Yavropoulou M., Efstathiou M., Foroglou N., Daniilidis M., & Kotsa K.
JournalMedicine (Baltimore)
Volume95
Issue2
Paginatione2358
Date Published2016 Jan
ISSN1536-5964
KeywordsAdenoma, Adult, Antineoplastic Agents, Hormonal, Bone Diseases, Metabolic, Humans, Male, Octreotide, Pericardial Effusion, Pituitary Neoplasms, Thyrotropin
Abstract

Increased bone turnover and other less frequent comorbidities of hyperthyroidism, such as heart failure, have only rarely been reported in association with central hyperthyroidism due to a thyrotropin (TSH)-secreting pituitary adenoma (TSHoma). Treatment is highly empirical and relies on eliminating the tumor and the hyperthyroid state.We report here an unusual case of a 39-year-old man who was initially admitted for management of pleuritic chest pain and fever of unknown origin. Diagnostic work up confirmed pericarditis and pleural effusion both refractory to treatment. The patient had a previous history of persistently elevated levels of alkaline phosphatase (ALP), indicative of increased bone turnover. He had also initially been treated with thyroxine supplementation due to elevated TSH levels. During the diagnostic process a TSHoma was revealed. Thyroxine was discontinued, and resection of the pituitary tumor followed by treatment with a somatostatin analog led to complete recession of the effusions, normalization of ALP, and shrinkage of pituitary tumor.Accelerated bone metabolism and pericardial and pleural effusions attributed to a TSHoma may resolve after successful treatment of the tumor. The unexpected clinical course of this case highlights the need for careful long-term surveillance in patients with these rare pituitary adenomas.

DOI10.1097/MD.0000000000002358
Alternate JournalMedicine (Baltimore)
PubMed ID26765410
PubMed Central IDPMC4718236

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.